-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OIPCU1zjc/3JS3GgB1GALCshBxOBSAj49uJTUujJhuCSZlJDnFMBQJDeUoHC+FTy i2MiiMFCF1qcDBvaMbH/dw== 0000950137-04-002178.txt : 20040325 0000950137-04-002178.hdr.sgml : 20040325 20040325125453 ACCESSION NUMBER: 0000950137-04-002178 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040325 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PRINCETON NATIONAL BANCORP INC CENTRAL INDEX KEY: 0000707855 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 363210283 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-50149 FILM NUMBER: 04689101 BUSINESS ADDRESS: STREET 1: 606 S MAIN ST CITY: PRINCETON STATE: IL ZIP: 61356 BUSINESS PHONE: 8158754444 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WILSON JAMES H CENTRAL INDEX KEY: 0001121984 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 910 SHERWOOD GLEN CITY: PRINCETON STATE: IL ZIP: 61356 BUSINESS PHONE: 8158727341 MAIL ADDRESS: STREET 1: 910 SHERWOOD GLEN CITY: PRINCETON STATE: IL ZIP: 61356 SC 13D/A 1 c84035a6sc13dza.txt AMENDMENT TO SCHEDULE 13D SCHEDULE 13D (RULE 13d-101) Information to be Included in Statements Filed Pursuant to Rule 13d-1(a) and Amendments Thereto Filed Pursuant to Rule 13d-2(a) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Princeton National Bancorp, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 742282106 - -------------------------------------------------------------------------------- (CUSIP Number) James V. Stepleton Husch & Eppenberger, LLC 190 Corondelet Plaza, Suite 600 St. Louis, Missouri 63105 (314) 480-1500 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 24, 2004 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box / /. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 742282106 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) James H. Wilson, M.D. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 147,800 shares of Common Stock SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 1,800 OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 147,800 shares of Common Stock PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 1,800 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 149,700 shares of Common Stock, consisting of 147,800 shares of Common Stock held directly, 100 shares of Common Stock held indirectly, and 1,800 shares held directly jointly with his wife or indirectly by his wife - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.8% of the Common Stock - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- CUSIP NO. 742282106 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Princeton Orthopedic Clinic, S.C. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) Not applicable - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 100 shares of Common Stock, included within the shares owned by Dr. Wilson SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 100 shares of Common Stock, included within the shares owned by Dr. Wilson PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 100 shares of Common Stock owned directly - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) Less than 0.1% of the Common Stock - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) CO - -------------------------------------------------------------------------------- ITEM 1. SECURITY AND ISSUER No change. ITEM 2. IDENTITY AND BACKGROUND No change. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Dr. Wilson funded the purchase of 200 shares from his personal funds. ITEM 4. PURPOSE OF TRANSACTION. No change ITEM 5. INTERESTS IN SECURITIES OF THE ISSUER. (a) Dr. Wilson beneficially owns 4.8%, of the Issuer's Common Stock, or 149,700 shares of Common Stock, consisting of 147,800 shares of Common Stock held directly, 100 shares of Common Stock held indirectly through the Clinic, which he controls, and 1,800 shares held jointly with or held by his wife. The Clinic beneficially owns less than 0.1% of the Common Stock of the Issuer, or 100 shares of Common Stock held directly. Dr. Wilson's wife or Dr. Wilson and his wife jointly hold less than 0.1% of the Common Stock, or 1,800 shares held jointly or by his wife. As a group, Dr. Wilson, the Clinic, and Dr. Wilson's wife or Dr. Wilson and his wife jointly own 4.8% of the Issuer's Common Stock, or 149,700 shares. (b) Dr. Wilson beneficially owns the following number of shares of Common Stock with: Sole Voting Power: 147,800 shares of Common Stock Sole Dispositive Power: 147,800 shares of Common Stock Shared Voting Power: 1,800 shares of Common Stock Shared Dispositive Power: 1,800 shares of Common Stock The Clinic owns the following number of shares of Common Stock with: Sole Voting Power: 100 shares of Common Stock, which are included within the shares beneficially owned by Dr. Wilson. Sole Dispositive Power: 100 shares of Common Stock, which are included within the shares beneficially owned by Dr. Wilson. (c) During the sixty days preceding March 24, 2004, Dr. Wilson purchased and sold the shares specified below for the indicated amounts per share:
Date No. of Shares Purchased No. of Shares Sold Price Per Share ------- ----------------------- ------------------ --------------- 2/12/04 200 $ 28.46 2/12/04 5,000 28.47 3/01/04 5,000 28.53 3/11/04 1,000 28.65 3/24/04 20,000 28.60
Dr. Wilson effected all purchases and sales for cash on the Nasdaq National Market. (d) Not applicable. (e) March 24, 2004. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIP WITH RESPECT TO SECURITIES OF THE ISSUER Not applicable ITEM 7. MATERIAL TO BE FILED AS EXHIBITS Exhibit Description None 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Date: March 25, 2004 /s/James H. Wilson, M.D. ----------------------------------------------------- James H. Wilson, M.D. PRINCETON ORTHOPEDIC CLINIC, S.C. By: /s/James H. Wilson, M.D. -------------------------------------------- James H. Wilson, M.D. Title: Chief Executive Officer 5 -----END PRIVACY-ENHANCED MESSAGE-----